| Product NDC: | 64980-138 |
| Proprietary Name: | POTASSIUM CITRATE |
| Non Proprietary Name: | POTASSIUM CITRATE |
| Active Ingredient(s): | 1080 mg/1 & nbsp; POTASSIUM CITRATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 64980-138 |
| Labeler Name: | Rising Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077440 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060619 |
| Package NDC: | 64980-138-01 |
| Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (64980-138-01) |
| NDC Code | 64980-138-01 |
| Proprietary Name | POTASSIUM CITRATE |
| Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (64980-138-01) |
| Product NDC | 64980-138 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | POTASSIUM CITRATE |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20060619 |
| Marketing Category Name | ANDA |
| Labeler Name | Rising Pharmaceuticals, Inc. |
| Substance Name | POTASSIUM CITRATE |
| Strength Number | 1080 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC] |